Martin Shkreli, the former hedge fund manager criticized for buying a pharmaceutical company and ratcheting up the price of a life-saving drug, is in custody following a securities probe. Kaye Scholer corporate partner Evan Greebel was also arrested Thursday, and is accused of conspiring with Shkreli in part of the scheme.
A seven-count indictment unsealed in Brooklyn federal court today charged Shkreli with conspiracy to commit securities fraud, conspiracy to commit wire fraud and securities fraud. Greebel, of Scarsdale, New York, was charged with conspiracy to commit wire fraud. It was not immediately clear who will represent Greebel in court.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
